Univariate and multivariate analyses of DDA1 expression, nuclear p65 translocation, and clinical features such as gender and age, and clinical pathological stages further confirmed that DDA1, either alone or in combination with nuclear p65 translocation is an independent prognostic factor for high risk of tumor recurrence (Table 3). This evidence concerns the gene RELA and neoplasm.